-
1
-
-
84903729737
-
-
June, date last accessed
-
http://seer.cancer.gov/statfacts/html/lungb.html. (June 2013, date last accessed).
-
(2013)
-
-
-
2
-
-
84874048519
-
Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC?
-
Sacher AG, Le LW, Leighl NB et al. Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC? J Thorac Oncol 2013; 8: 366-368.
-
(2013)
J Thorac Oncol
, vol.8
, pp. 366-368
-
-
Sacher, A.G.1
Le, L.W.2
Leighl, N.B.3
-
3
-
-
77952743404
-
EORTC elderly task force position paper: approach to the older cancer patient
-
Pallis AG, Fortpied C, Wedding U et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010; 46: 1502-1513.
-
(2010)
Eur J Cancer
, vol.46
, pp. 1502-1513
-
-
Pallis, A.G.1
Fortpied, C.2
Wedding, U.3
-
4
-
-
77951498205
-
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population
-
Pallis AG, Gridelli C, van Meerbeeck JP et al. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol 2010; 21: 692-706.
-
(2010)
Ann Oncol
, vol.21
, pp. 692-706
-
-
Pallis, A.G.1
Gridelli, C.2
van Meerbeeck, J.P.3
-
5
-
-
84873928427
-
SEER Cancer Statistics Review, 1975-2010, National Cancer Institute
-
Bethesda, MD, based on November 2012 SEER data submission. posted to the SEER web site, April, June 2013, date last accessed
-
Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD; http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission. posted to the SEER web site, April 2013 (June 2013, date last accessed).
-
(2013)
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
-
6
-
-
84865499675
-
Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer
-
Giroux-Leprieur E, Labrune S, Giraud V et al. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer. Clin Lung Cancer 2012; 13: 363-368.
-
(2012)
Clin Lung Cancer
, vol.13
, pp. 363-368
-
-
Giroux-Leprieur, E.1
Labrune, S.2
Giraud, V.3
-
7
-
-
84857062389
-
The elderly patient with surgically resected non-small cell lung cancer-a distinct situation?
-
Sterlacci W, Stockinger R, Schmid T et al. The elderly patient with surgically resected non-small cell lung cancer-a distinct situation? Exp Gerontol 2012; 47: 237-242.
-
(2012)
Exp Gerontol
, vol.47
, pp. 237-242
-
-
Sterlacci, W.1
Stockinger, R.2
Schmid, T.3
-
8
-
-
70449580653
-
Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients
-
Goodgame B, Viswanathan A, Zoole J et al. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients. J Thorac Oncol 2009; 4: 1370-1374.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1370-1374
-
-
Goodgame, B.1
Viswanathan, A.2
Zoole, J.3
-
9
-
-
80053655288
-
Are we treating enough elderly patients with early stage nonsmall cell lung cancer?
-
Pallis AG, Scarci M. Are we treating enough elderly patients with early stage nonsmall cell lung cancer? Lung Cancer 2011; 74: 149-154.
-
(2011)
Lung Cancer
, vol.74
, pp. 149-154
-
-
Pallis, A.G.1
Scarci, M.2
-
10
-
-
79956187756
-
Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients
-
Takamochi K, Oh S, Matsuoka J et al. Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients. Interact Cardiovasc Thorac Surg 2011; 12: 739-743.
-
(2011)
Interact Cardiovasc Thorac Surg
, vol.12
, pp. 739-743
-
-
Takamochi, K.1
Oh, S.2
Matsuoka, J.3
-
11
-
-
84879587269
-
Mediastinal lymphadenectomy in elderly patients with non-small-cell lung cancer
-
Rivera C, Falcoz PE, Rami-Porta R et al. Mediastinal lymphadenectomy in elderly patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 2013; 44: 88-92.
-
(2013)
Eur J Cardiothorac Surg
, vol.44
, pp. 88-92
-
-
Rivera, C.1
Falcoz, P.E.2
Rami-Porta, R.3
-
12
-
-
84867902025
-
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial
-
Tsao AS, Liu S, Lee JJ et al. Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial. J Thorac Oncol 2012; 7: 1645-1652.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 1645-1652
-
-
Tsao, A.S.1
Liu, S.2
Lee, J.J.3
-
13
-
-
79961108629
-
Reduced lung-cancer mortality with lowdose computed tomographic screening
-
Aberle DR, Adams AM, Berg CD et al. Reduced lung-cancer mortality with lowdose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
-
(2011)
N Engl J Med
, vol.365
, pp. 395-409
-
-
Aberle, D.R.1
Adams, A.M.2
Berg, C.D.3
-
14
-
-
33645346222
-
Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials
-
Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Intern Med J 2006; 36: 216-220.
-
(2006)
Intern Med J
, vol.36
, pp. 216-220
-
-
Jennens, R.R.1
Giles, G.G.2
Fox, R.M.3
-
15
-
-
0035919184
-
Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization
-
Walter LC, Brand RJ, Counsell SR et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 2001; 285: 2987-2994.
-
(2001)
JAMA
, vol.285
, pp. 2987-2994
-
-
Walter, L.C.1
Brand, R.J.2
Counsell, S.R.3
-
16
-
-
84903693632
-
-
September, date last accessed
-
http://globocan.iarc.fr/. (September 2013, date last accessed).
-
(2013)
-
-
-
17
-
-
84862588825
-
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
-
Jaklitsch MT, Jacobson FL, Austin JH et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012; 144: 33-38.
-
(2012)
J Thorac Cardiovasc Surg
, vol.144
, pp. 33-38
-
-
Jaklitsch, M.T.1
Jacobson, F.L.2
Austin, J.H.3
-
18
-
-
84862601972
-
Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance
-
Jacobson FL, Austin JH, Field JK et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012; 144: 25-32.
-
(2012)
J Thorac Cardiovasc Surg
, vol.144
, pp. 25-32
-
-
Jacobson, F.L.1
Austin, J.H.2
Field, J.K.3
-
19
-
-
84883228184
-
Lung Cancer Screening
-
NCCN guidelines Version 1.2014, September, date last accessed
-
NCCN guidelines Version 1.2014. Lung Cancer Screening. www.nccn.org (September 2013, date last accessed).
-
(2013)
-
-
-
20
-
-
0035816019
-
Cancer screening in elderly patients: a framework for individualized decision making
-
Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-2756.
-
(2001)
JAMA
, vol.285
, pp. 2750-2756
-
-
Walter, L.C.1
Covinsky, K.E.2
-
21
-
-
33748445900
-
Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities
-
Lewis CL, Kistler CE, Amick HR et al. Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatr 2006; 6: 10.
-
(2006)
BMC Geriatr
, vol.6
, pp. 10
-
-
Lewis, C.L.1
Kistler, C.E.2
Amick, H.R.3
-
22
-
-
84876054911
-
Older adults and forgoing cancer screening: 'I think it would be strange'
-
Torke AM, Schwartz PH, Holtz LR et al. Older adults and forgoing cancer screening: 'I think it would be strange'. JAMA Intern Med 2013; 173: 526-531.
-
(2013)
JAMA Intern Med
, vol.173
, pp. 526-531
-
-
Torke, A.M.1
Schwartz, P.H.2
Holtz, L.R.3
-
23
-
-
84870525789
-
Estimating overdiagnosis in lowdose computed tomography screening for lung cancer: a cohort study
-
Veronesi G, Maisonneuve P, Bellomi M et al. Estimating overdiagnosis in lowdose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012; 157: 776-784.
-
(2012)
Ann Intern Med
, vol.157
, pp. 776-784
-
-
Veronesi, G.1
Maisonneuve, P.2
Bellomi, M.3
-
25
-
-
79955584277
-
Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit
-
Rivera C, Dahan M, Bernard A et al. Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit. Eur J Cardiothorac Surg 2011; 39: 981-986.
-
(2011)
Eur J Cardiothorac Surg
, vol.39
, pp. 981-986
-
-
Rivera, C.1
Dahan, M.2
Bernard, A.3
-
26
-
-
80053468909
-
Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested casecontrol study
-
Rivera C, Falcoz PE, Bernard A et al. Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested casecontrol study. Chest 2011; 140: 874-880.
-
(2011)
Chest
, vol.140
, pp. 874-880
-
-
Rivera, C.1
Falcoz, P.E.2
Bernard, A.3
-
28
-
-
84862996288
-
Impact of age and comorbidity on nonsmall- cell lung cancer treatment in older veterans
-
Wang S, Wong ML, Hamilton N et al. Impact of age and comorbidity on nonsmall- cell lung cancer treatment in older veterans. J Clin Oncol 2012; 30: 1447-1455.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1447-1455
-
-
Wang, S.1
Wong, M.L.2
Hamilton, N.3
-
29
-
-
77953166788
-
Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?
-
Palma DA, Tyldesley S, Sheehan F et al. Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment? J Thorac Oncol 2010; 5: 818-824.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 818-824
-
-
Palma, D.A.1
Tyldesley, S.2
Sheehan, F.3
-
30
-
-
84858310285
-
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years
-
van der Drift MA, Karim-Kos HE, Siesling S et al. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol 2012; 7: 291-298.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 291-298
-
-
van der Drift, M.A.1
Karim-Kos, H.E.2
Siesling, S.3
-
31
-
-
84864336455
-
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands
-
Haasbeek CJ, Palma D, Visser O et al. Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol 2012; 23: 2743-2747.
-
(2012)
Ann Oncol
, vol.23
, pp. 2743-2747
-
-
Haasbeek, C.J.1
Palma, D.2
Visser, O.3
-
32
-
-
84857372522
-
Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer
-
Gray SW, Landrum MB, Lamont EB et al. Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer. Cancer 2012; 118: 1404-1411.
-
(2012)
Cancer
, vol.118
, pp. 1404-1411
-
-
Gray, S.W.1
Landrum, M.B.2
Lamont, E.B.3
-
33
-
-
77954558192
-
In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?
-
Chambers A, Routledge T, Pilling J et al. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life? Interact Cardiovasc Thorac Surg 2010; 10: 1015-1021.
-
(2010)
Interact Cardiovasc Thorac Surg
, vol.10
, pp. 1015-1021
-
-
Chambers, A.1
Routledge, T.2
Pilling, J.3
-
34
-
-
84861182392
-
Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population
-
Rueth NM, Parsons HM, Habermann EB et al. Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population. J Thorac Cardiovasc Surg 2012; 143: 1314-1323.
-
(2012)
J Thorac Cardiovasc Surg
, vol.143
, pp. 1314-1323
-
-
Rueth, N.M.1
Parsons, H.M.2
Habermann, E.B.3
-
35
-
-
0021077394
-
Modern thirty-day operative mortality for surgical resections in lung cancer
-
Ginsberg RJ, Hill LD, Eagan RT et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86: 654-658.
-
(1983)
J Thorac Cardiovasc Surg
, vol.86
, pp. 654-658
-
-
Ginsberg, R.J.1
Hill, L.D.2
Eagan, R.T.3
-
36
-
-
32644490550
-
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial
-
Allen MS, Darling GE, Pechet TT et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006; 81: 1013-1019.
-
(2006)
Ann Thorac Surg
, vol.81
, pp. 1013-1019
-
-
Allen, M.S.1
Darling, G.E.2
Pechet, T.T.3
-
37
-
-
31044432516
-
Video-assisted thoracic surgery lobectomy: experience with 1,100 cases
-
McKenna RJ, Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006; 81: 421-425.
-
(2006)
Ann Thorac Surg
, vol.81
, pp. 421-425
-
-
McKenna Jr., R.J.1
Houck, W.2
Fuller, C.B.3
-
38
-
-
33747706089
-
Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients
-
Onaitis MW, Petersen RP, Balderson SS et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006; 244: 420-425.
-
(2006)
Ann Surg
, vol.244
, pp. 420-425
-
-
Onaitis, M.W.1
Petersen, R.P.2
Balderson, S.S.3
-
39
-
-
84873914652
-
Predictors of nursing home admission, severe functional impairment, or death one year after surgery for non-small cell lung cancer
-
Billmeier SE, Ayanian JZ, He Y et al. Predictors of nursing home admission, severe functional impairment, or death one year after surgery for non-small cell lung cancer. Ann Surg 2013; 257: 555-563.
-
(2013)
Ann Surg
, vol.257
, pp. 555-563
-
-
Billmeier, S.E.1
Ayanian, J.Z.2
He, Y.3
-
40
-
-
34648860551
-
Factors predicting poor survival after resection of stage IA non-small cell lung cancer
-
Chang MY, Mentzer SJ, Colson YL et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2007; 134: 850-856.
-
(2007)
J Thorac Cardiovasc Surg
, vol.134
, pp. 850-856
-
-
Chang, M.Y.1
Mentzer, S.J.2
Colson, Y.L.3
-
41
-
-
49449084091
-
Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia
-
Wong DR, Henteleff HJ. Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia. Can J Surg 2008; 51: 257-262.
-
(2008)
Can J Surg
, vol.51
, pp. 257-262
-
-
Wong, D.R.1
Henteleff, H.J.2
-
42
-
-
0029089012
-
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group
-
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615-622.
-
(1995)
Ann Thorac Surg
, vol.60
, pp. 615-622
-
-
Ginsberg, R.J.1
Rubinstein, L.V.2
-
43
-
-
79953846668
-
Pneumonectomy vs. sleeve resection for non-small cell lung carcinoma in the elderly: analysis of short-term and longterm results
-
Bolukbas S, Eberlein MH, Schirren J. Pneumonectomy vs. sleeve resection for non-small cell lung carcinoma in the elderly: analysis of short-term and longterm results. Thorac Cardiovasc Surg 2011; 59: 142-147.
-
(2011)
Thorac Cardiovasc Surg
, vol.59
, pp. 142-147
-
-
Bolukbas, S.1
Eberlein, M.H.2
Schirren, J.3
-
44
-
-
78049265892
-
Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer
-
Okami J, Ito Y, Higashiyama M et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg 2010; 90: 1651-1656.
-
(2010)
Ann Thorac Surg
, vol.90
, pp. 1651-1656
-
-
Okami, J.1
Ito, Y.2
Higashiyama, M.3
-
45
-
-
84868357354
-
Clinical controlled comparison between lobectomy and segmental resection for patients over 70 years of age with clinical stage I non-small cell lung cancer
-
Cheng YD, Duan CJ, Dong S et al. Clinical controlled comparison between lobectomy and segmental resection for patients over 70 years of age with clinical stage I non-small cell lung cancer. Eur J Surg Oncol 2012; 38: 1149-1155.
-
(2012)
Eur J Surg Oncol
, vol.38
, pp. 1149-1155
-
-
Cheng, Y.D.1
Duan, C.J.2
Dong, S.3
-
46
-
-
77953292120
-
Can non-performance of radical systematic mediastinal lymphadenectomy be justified in elderly lung cancer patients? An evaluation using propensity-based survival analysis
-
Okasaka T, Usami N, Taniguchi T et al. Can non-performance of radical systematic mediastinal lymphadenectomy be justified in elderly lung cancer patients? An evaluation using propensity-based survival analysis. Eur J Cardiothorac Surg 2010; 38: 27-33.
-
(2010)
Eur J Cardiothorac Surg
, vol.38
, pp. 27-33
-
-
Okasaka, T.1
Usami, N.2
Taniguchi, T.3
-
47
-
-
84860287671
-
Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly
-
Shapiro M, Mhango G, Kates M et al. Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly. Eur J Surg Oncol 2012; 38: 516-522.
-
(2012)
Eur J Surg Oncol
, vol.38
, pp. 516-522
-
-
Shapiro, M.1
Mhango, G.2
Kates, M.3
-
48
-
-
84863745484
-
Pneumonectomy for non-small cell lung cancer: outcomes analysis
-
Kalathiya RJ, Saha SP. Pneumonectomy for non-small cell lung cancer: outcomes analysis. South Med J 2012; 105: 350-354.
-
(2012)
South Med J
, vol.105
, pp. 350-354
-
-
Kalathiya, R.J.1
Saha, S.P.2
-
49
-
-
77954559180
-
Pneumonectomy for lung cancer over the age of 75 years: is it worthwhile?
-
Zuin A, Marulli G, Breda C et al. Pneumonectomy for lung cancer over the age of 75 years: is it worthwhile? Interact Cardiovasc Thorac Surg 2010; 10: 931-935.
-
(2010)
Interact Cardiovasc Thorac Surg
, vol.10
, pp. 931-935
-
-
Zuin, A.1
Marulli, G.2
Breda, C.3
-
50
-
-
81855228625
-
Lobectomy in octogenarians with non-small cell lung cancer: ramifications of increasing life expectancy and the benefits of minimally invasive surgery
-
Port JL, Mirza FM, Lee PC et al. Lobectomy in octogenarians with non-small cell lung cancer: ramifications of increasing life expectancy and the benefits of minimally invasive surgery. Ann Thorac Surg 2011; 92: 1951-1957.
-
(2011)
Ann Thorac Surg
, vol.92
, pp. 1951-1957
-
-
Port, J.L.1
Mirza, F.M.2
Lee, P.C.3
-
51
-
-
79958161531
-
Thoracic surgery in octogenarians: CVTSA/Inova Fairfax hospital experience, 1990 to 2009
-
Kiernan PD, Khandhar SJ, Fortes DL et al. Thoracic surgery in octogenarians: CVTSA/Inova Fairfax hospital experience, 1990 to 2009. Am Surg 2011; 77: 675-680.
-
(2011)
Am Surg
, vol.77
, pp. 675-680
-
-
Kiernan, P.D.1
Khandhar, S.J.2
Fortes, D.L.3
-
52
-
-
76149089845
-
Video-assisted thoracic surgery lobectomy for non-small cell lung cancer in patients with a Charlson comorbidity index score of two or more
-
Nakanishi R, Yamashita T, Oka S. Video-assisted thoracic surgery lobectomy for non-small cell lung cancer in patients with a Charlson comorbidity index score of two or more. J Thorac Oncol 2010; 5: 56-61.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 56-61
-
-
Nakanishi, R.1
Yamashita, T.2
Oka, S.3
-
53
-
-
37249040961
-
Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications
-
Cattaneo SM, Park BJ, Wilton AS et al. Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications. Ann Thorac Surg 2008; 85: 231-235.
-
(2008)
Ann Thorac Surg
, vol.85
, pp. 231-235
-
-
Cattaneo, S.M.1
Park, B.J.2
Wilton, A.S.3
-
54
-
-
76749152020
-
Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer
-
Wisnivesky JP, Halm E, Bonomi M et al. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med 2010; 181: 264-269.
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 264-269
-
-
Wisnivesky, J.P.1
Halm, E.2
Bonomi, M.3
-
55
-
-
79952002656
-
Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer
-
Palma D, Senan S. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Curr Opin Oncol 2011; 23: 133-139.
-
(2011)
Curr Opin Oncol
, vol.23
, pp. 133-139
-
-
Palma, D.1
Senan, S.2
-
56
-
-
84876147767
-
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review
-
Senthi S, Haasbeek CJ, Slotman BJ et al. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother Oncol 2013; 106: 276-282.
-
(2013)
Radiother Oncol
, vol.106
, pp. 276-282
-
-
Senthi, S.1
Haasbeek, C.J.2
Slotman, B.J.3
-
57
-
-
79951864385
-
Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis
-
Palma D, Visser O, Lagerwaard FJ et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010; 28: 5153-5159.
-
(2010)
J Clin Oncol
, vol.28
, pp. 5153-5159
-
-
Palma, D.1
Visser, O.2
Lagerwaard, F.J.3
-
58
-
-
81755161522
-
Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery
-
Palma D, Visser O, Lagerwaard FJ et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 2011; 101: 240-244.
-
(2011)
Radiother Oncol
, vol.101
, pp. 240-244
-
-
Palma, D.1
Visser, O.2
Lagerwaard, F.J.3
-
59
-
-
84869143086
-
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly
-
Shirvani SM, Jiang J, Chang JY et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012; 84: 1060-1070.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.84
, pp. 1060-1070
-
-
Shirvani, S.M.1
Jiang, J.2
Chang, J.Y.3
-
60
-
-
84863937504
-
Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada
-
Cuffe S, Booth CM, Peng Y et al. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada. J Clin Oncol 2012; 30: 1813-1821.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1813-1821
-
-
Cuffe, S.1
Booth, C.M.2
Peng, Y.3
-
61
-
-
84878447977
-
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer
-
Park S, Kim IR, Baek KK et al. Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer. Ann Oncol 2013; 24: 1630-1639.
-
(2013)
Ann Oncol
, vol.24
, pp. 1630-1639
-
-
Park, S.1
Kim, I.R.2
Baek, K.K.3
-
62
-
-
84859425700
-
Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients?
-
Rivera C, Jougon J, Dahan M et al. Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients? Lung Cancer 2012; 76: 216-221.
-
(2012)
Lung Cancer
, vol.76
, pp. 216-221
-
-
Rivera, C.1
Jougon, J.2
Dahan, M.3
-
63
-
-
84865972826
-
Postoperative radiotherapy for elderly patients with stage III lung cancer
-
Wisnivesky JP, Halm EA, Bonomi M et al. Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer 2012; 118: 4478-4485.
-
(2012)
Cancer
, vol.118
, pp. 4478-4485
-
-
Wisnivesky, J.P.1
Halm, E.A.2
Bonomi, M.3
-
64
-
-
79951773013
-
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer
-
Coate LE, Massey C, Hope A et al. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer. J Thorac Oncol 2011; 6: 537-544.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 537-544
-
-
Coate, L.E.1
Massey, C.2
Hope, A.3
-
65
-
-
82255186389
-
Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study
-
Wanders R, Steevens J, Botterweck A et al. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study. Eur J Cancer 2011; 47: 2691-2697.
-
(2011)
Eur J Cancer
, vol.47
, pp. 2691-2697
-
-
Wanders, R.1
Steevens, J.2
Botterweck, A.3
-
66
-
-
79955485075
-
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer
-
Davidoff AJ, Gardner JF, Seal B et al. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer. J Thorac Oncol 2011; 6: 934-941.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 934-941
-
-
Davidoff, A.J.1
Gardner, J.F.2
Seal, B.3
-
67
-
-
77950458224
-
Radiotherapy for lung cancer in the elderly
-
Bayman N, Alam N, Faivre-Finn C. Radiotherapy for lung cancer in the elderly. Lung Cancer 2010; 68: 129-136.
-
(2010)
Lung Cancer
, vol.68
, pp. 129-136
-
-
Bayman, N.1
Alam, N.2
Faivre-Finn, C.3
-
68
-
-
84863087900
-
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)
-
Atagi S, Kawahara M, Yokoyama A et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol 2012; 13: 671-678.
-
(2012)
Lancet Oncol
, vol.13
, pp. 671-678
-
-
Atagi, S.1
Kawahara, M.2
Yokoyama, A.3
-
69
-
-
84895559882
-
Non-Small Cell Lung Cancer version 2
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), 2013 (June 2013, date last accessed
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non-Small Cell Lung Cancer version 2.2013; http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. 2013 (June 2013, date last accessed)
-
(2013)
-
-
-
70
-
-
77949541182
-
Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know?
-
Pallis AG, Wedding U, Lacombe D et al. Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know? Eur J Cancer 2010; 46: 1019-1025.
-
(2010)
Eur J Cancer
, vol.46
, pp. 1019-1025
-
-
Pallis, A.G.1
Wedding, U.2
Lacombe, D.3
-
71
-
-
84865450666
-
Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer
-
Gridelli C, Brodowicz T, Langer CJ et al. Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer. Clin Lung Cancer 2012; 13: 340-346.
-
(2012)
Clin Lung Cancer
, vol.13
, pp. 340-346
-
-
Gridelli, C.1
Brodowicz, T.2
Langer, C.J.3
-
72
-
-
84867503374
-
Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70-74, 75-79, and 80 or older in Japan
-
Kawaguchi T, Tamiya A, Tamura A et al. Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70-74, 75-79, and 80 or older in Japan. Clin Lung Cancer 2012; 13: 442-447.
-
(2012)
Clin Lung Cancer
, vol.13
, pp. 442-447
-
-
Kawaguchi, T.1
Tamiya, A.2
Tamura, A.3
-
73
-
-
77952311362
-
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer
-
Davidoff AJ, Tang M, Seal B et al. Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2010; 28: 2191-2197.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2191-2197
-
-
Davidoff, A.J.1
Tang, M.2
Seal, B.3
-
74
-
-
84878112026
-
Comparative effectiveness of three platinumdoublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer
-
Zhu J, Sharma DB, Chen AB et al. Comparative effectiveness of three platinumdoublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer. Cancer 2013; 119: 2048-2060.
-
(2013)
Cancer
, vol.119
, pp. 2048-2060
-
-
Zhu, J.1
Sharma, D.B.2
Chen, A.B.3
-
75
-
-
77449086119
-
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer
-
Chrischilles EA, Pendergast JF, Kahn KL et al. Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 2010; 28: 620-627.
-
(2010)
J Clin Oncol
, vol.28
, pp. 620-627
-
-
Chrischilles, E.A.1
Pendergast, J.F.2
Kahn, K.L.3
-
76
-
-
79959613188
-
Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer: a hellenic oncology research group randomized phase III study
-
Karampeazis A, Vamvakas L, Agelidou A et al. Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer: a hellenic oncology research group randomized phase III study. Clin Lung Cancer 2011; 12: 155-160.
-
(2011)
Clin Lung Cancer
, vol.12
, pp. 155-160
-
-
Karampeazis, A.1
Vamvakas, L.2
Agelidou, A.3
-
77
-
-
80052964872
-
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
-
Quoix E, Zalcman G, Oster JP et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 2011; 378: 1079-1088.
-
(2011)
Lancet
, vol.378
, pp. 1079-1088
-
-
Quoix, E.1
Zalcman, G.2
Oster, J.P.3
-
78
-
-
0018830819
-
Prognostic factors for survival in patients with inoperable lung cancer
-
Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980; 65: 25-32.
-
(1980)
J Natl Cancer Inst
, vol.65
, pp. 25-32
-
-
Stanley, K.E.1
-
79
-
-
0034749950
-
Weight change in old age and its association with mortality
-
Newman AB, Yanez D, Harris T et al. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001; 49: 1309-1318.
-
(2001)
J Am Geriatr Soc
, vol.49
, pp. 1309-1318
-
-
Newman, A.B.1
Yanez, D.2
Harris, T.3
-
80
-
-
84875448911
-
Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study
-
Kenis C, Bron D, Libert Y et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013; 24: 1306-12.
-
(2013)
Ann Oncol
, vol.24
, pp. 1306-1312
-
-
Kenis, C.1
Bron, D.2
Libert, Y.3
-
81
-
-
80052962512
-
Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients ( pts) with advanced non-small cell lung cancer (NSCLC): an intergroup trial of JCOG0803/WJOG4307L
-
abstr
-
Abe T, Yokoyama A, Takeda K et al. Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients ( pts) with advanced non-small cell lung cancer (NSCLC): an intergroup trial of JCOG0803/WJOG4307L. J Clin Oncol 2011; 29: abstr 7509.
-
(2011)
J Clin Oncol
, vol.29
, pp. 7509
-
-
Abe, T.1
Yokoyama, A.2
Takeda, K.3
-
82
-
-
84863957748
-
Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial
-
Socinski MA, Bondarenko I, Karaseva NA et al. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. J Clin Oncol 2012; 30: 2055-2062.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2055-2062
-
-
Socinski, M.A.1
Bondarenko, I.2
Karaseva, N.A.3
-
83
-
-
84873866422
-
Safety and efficacy of weekly nab(R)- paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer
-
Socinski MA, Langer CJ, Okamoto I et al. Safety and efficacy of weekly nab(R)- paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer. Ann Oncol 2013; 24: 314-321.
-
(2013)
Ann Oncol
, vol.24
, pp. 314-321
-
-
Socinski, M.A.1
Langer, C.J.2
Okamoto, I.3
-
84
-
-
84655163441
-
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer
-
Spigel DR, Hainsworth JD, Shipley DL et al. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. J Thorac Oncol 2012; 7: 196-202.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 196-202
-
-
Spigel, D.R.1
Hainsworth, J.D.2
Shipley, D.L.3
-
85
-
-
84867535247
-
Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution
-
Inal A, Kaplan MA, Kucukoner M et al. Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution. J BUON 2012; 17: 533-536.
-
(2012)
J BUON
, vol.17
, pp. 533-536
-
-
Inal, A.1
Kaplan, M.A.2
Kucukoner, M.3
-
86
-
-
84555206070
-
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous nonsmall cell lung cancer: safety of avastin in lung trial (MO19390)
-
Laskin J, Crino L, Felip E et al. Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous nonsmall cell lung cancer: safety of avastin in lung trial (MO19390). J Thorac Oncol 2012; 7: 203-211.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 203-211
-
-
Laskin, J.1
Crino, L.2
Felip, E.3
-
87
-
-
79960183862
-
Clinical outcomes (CO) for special populations of patients ( pts) with advanced non-small cell lung cancer (NSCLC): results from ARIES, a bevacizumab (BV) observational cohort study (OCS)
-
abstr
-
Wozniak AJ, Garst J, Jahanzeb M et al. Clinical outcomes (CO) for special populations of patients ( pts) with advanced non-small cell lung cancer (NSCLC): results from ARIES, a bevacizumab (BV) observational cohort study (OCS). J Clin Oncol 2013; 28: abstr 7618.
-
(2013)
J Clin Oncol
, vol.28
, pp. 7618
-
-
Wozniak, A.J.1
Garst, J.2
Jahanzeb, M.3
-
88
-
-
84859851347
-
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
-
Zhu J, Sharma DB, Gray SW et al. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA 2012; 307: 1593-1601.
-
(2012)
JAMA
, vol.307
, pp. 1593-1601
-
-
Zhu, J.1
Sharma, D.B.2
Gray, S.W.3
-
89
-
-
84865686581
-
First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study
-
Maemondo M, Minegishi Y, Inoue A et al. First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. J Thorac Oncol 2012; 7: 1417-1422.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 1417-1422
-
-
Maemondo, M.1
Minegishi, Y.2
Inoue, A.3
-
90
-
-
63049132774
-
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy
-
Inoue A, Kobayashi K, Usui K et al. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol 2009; 27: 1394-1400.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1394-1400
-
-
Inoue, A.1
Kobayashi, K.2
Usui, K.3
-
91
-
-
80155135291
-
Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study
-
Asami K, Koizumi T, Hirai K et al. Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study. Clin Lung Cancer 2011; 12: 387-392.
-
(2011)
Clin Lung Cancer
, vol.12
, pp. 387-392
-
-
Asami, K.1
Koizumi, T.2
Hirai, K.3
-
92
-
-
84858339030
-
Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older
-
Chen YM, Tsai CM, Fan WC et al. Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older. J Thorac Oncol 2012; 7: 412-418.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 412-418
-
-
Chen, Y.M.1
Tsai, C.M.2
Fan, W.C.3
-
93
-
-
80052273497
-
A randomized phase II trial of firstline treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer
-
Stinchcombe TE, Peterman AH, Lee CB et al. A randomized phase II trial of firstline treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. J Thorac Oncol 2011; 6: 1569-1577.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1569-1577
-
-
Stinchcombe, T.E.1
Peterman, A.H.2
Lee, C.B.3
-
94
-
-
84875394397
-
A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer
-
Stinchcombe TE, Roder J, Peterman AH et al. A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer. J Thorac Oncol 2013; 8: 443-451.
-
(2013)
J Thorac Oncol
, vol.8
, pp. 443-451
-
-
Stinchcombe, T.E.1
Roder, J.2
Peterman, A.H.3
-
95
-
-
84879952863
-
Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77
-
Riggs H, Jalal SI, Baghdadi TA et al. Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77. Clin Lung Cancer 2013; 14: 224-229.
-
(2013)
Clin Lung Cancer
, vol.14
, pp. 224-229
-
-
Riggs, H.1
Jalal, S.I.2
Baghdadi, T.A.3
-
96
-
-
84863484785
-
Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer
-
Merimsky O, Cheng CK, Au JS et al. Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer. Oncol Rep 2012; 28: 721-727.
-
(2012)
Oncol Rep
, vol.28
, pp. 721-727
-
-
Merimsky, O.1
Cheng, C.K.2
Au, J.S.3
-
97
-
-
77649322365
-
Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients
-
Wu CH, Fan WC, Chen YM et al. Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients. J Thorac Oncol 2010; 5: 376-379.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 376-379
-
-
Wu, C.H.1
Fan, W.C.2
Chen, Y.M.3
-
98
-
-
59349098615
-
Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study
-
Repetto L, Piselli P, Raffaele M et al. Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study. Eur J Cancer 2009; 45: 374-383.
-
(2009)
Eur J Cancer
, vol.45
, pp. 374-383
-
-
Repetto, L.1
Piselli, P.2
Raffaele, M.3
-
99
-
-
84860753771
-
Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians
-
Girones R, Torregrosa D, Gomez-Codina J et al. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians. Clin Transl Oncol 2012; 14: 183-189.
-
(2012)
Clin Transl Oncol
, vol.14
, pp. 183-189
-
-
Girones, R.1
Torregrosa, D.2
Gomez-Codina, J.3
-
100
-
-
34047181030
-
The illness trajectory of elderly cancer patients across cultures: SIOG position paper
-
Surbone A, Kagawa-Singer M, Terret C et al. The illness trajectory of elderly cancer patients across cultures: SIOG position paper. Ann Oncol 2007; 18: 633-638.
-
(2007)
Ann Oncol
, vol.18
, pp. 633-638
-
-
Surbone, A.1
Kagawa-Singer, M.2
Terret, C.3
-
101
-
-
77954142193
-
Patients' preferences for chemotherapy in nonsmall- cell lung cancer: a systematic review
-
Blinman P, Alam M, Duric V et al. Patients' preferences for chemotherapy in nonsmall- cell lung cancer: a systematic review. Lung Cancer 2010; 69: 141-147.
-
(2010)
Lung Cancer
, vol.69
, pp. 141-147
-
-
Blinman, P.1
Alam, M.2
Duric, V.3
-
102
-
-
35848932490
-
Non-small cell lung cancer in octogenarians: treatment practices and preferences
-
Oxnard GR, Fidias P, Muzikansky A et al. Non-small cell lung cancer in octogenarians: treatment practices and preferences. J Thorac Oncol 2007; 2: 1029-1035.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 1029-1035
-
-
Oxnard, G.R.1
Fidias, P.2
Muzikansky, A.3
-
103
-
-
77955877759
-
Early palliative care for patients with metastatic non-small-cell lung cancer
-
Temel JS, Greer JA, Muzikansky A et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
-
(2010)
N Engl J Med
, vol.363
, pp. 733-742
-
-
Temel, J.S.1
Greer, J.A.2
Muzikansky, A.3
-
104
-
-
0032713603
-
A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly
-
Monfardini S, Balducci L. A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly. Eur J Cancer 1999; 35: 1771-1772.
-
(1999)
Eur J Cancer
, vol.35
, pp. 1771-1772
-
-
Monfardini, S.1
Balducci, L.2
-
105
-
-
0027420644
-
Comprehensive geriatric assessment: a meta-analysis of controlled trials
-
Stuck AE, Siu AL, Wieland GD et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342: 1032-1036.
-
(1993)
Lancet
, vol.342
, pp. 1032-1036
-
-
Stuck, A.E.1
Siu, A.L.2
Wieland, G.D.3
-
106
-
-
80053056355
-
Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study
-
Caillet P, Canoui-Poitrine F, Vouriot J et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011; 29: 3636-3642.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3636-3642
-
-
Caillet, P.1
Canoui-Poitrine, F.2
Vouriot, J.3
-
107
-
-
51449098376
-
Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?
-
Girre V, Falcou MC, Gisselbrecht M et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? J Gerontol A Biol Sci Med Sci 2008; 63: 724-730.
-
(2008)
J Gerontol A Biol Sci Med Sci
, vol.63
, pp. 724-730
-
-
Girre, V.1
Falcou, M.C.2
Gisselbrecht, M.3
-
108
-
-
80052704591
-
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
-
Hurria A, Togawa K, Mohile SG et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011; 29: 3457-3465.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3457-3465
-
-
Hurria, A.1
Togawa, K.2
Mohile, S.G.3
-
109
-
-
84862575323
-
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
-
Extermann M, Boler I, Reich RR et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012; 118: 3377-3386.
-
(2012)
Cancer
, vol.118
, pp. 3377-3386
-
-
Extermann, M.1
Boler, I.2
Reich, R.R.3
-
110
-
-
0035661510
-
The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community
-
Saliba D, Elliott M, Rubenstein LZ et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001; 49: 1691-1699.
-
(2001)
J Am Geriatr Soc
, vol.49
, pp. 1691-1699
-
-
Saliba, D.1
Elliott, M.2
Rubenstein, L.Z.3
-
111
-
-
77951624378
-
Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13
-
Luciani A, Ascione G, Bertuzzi C et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010; 28: 2046-2050.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2046-2050
-
-
Luciani, A.1
Ascione, G.2
Bertuzzi, C.3
-
112
-
-
84858305605
-
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
-
Bellera CA, Rainfray M, Mathoulin-Pelissier S et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012; 23: 2166-72.
-
(2012)
Ann Oncol
, vol.23
, pp. 2166-2172
-
-
Bellera, C.A.1
Rainfray, M.2
Mathoulin-Pelissier, S.3
-
113
-
-
33745854156
-
Vulnerability in the elderly: frailty
-
Slaets JP. Vulnerability in the elderly: frailty. Med Clin North Am 2006; 90: 593-601.
-
(2006)
Med Clin North Am
, vol.90
, pp. 593-601
-
-
Slaets, J.P.1
-
114
-
-
84861657407
-
Nonreferral of nursing home patients with suspected breast cancer
-
Hamaker ME, Hamelinck VC, van Munster BC et al. Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc 2012; 13: 464-469.
-
(2012)
J Am Med Dir Assoc
, vol.13
, pp. 464-469
-
-
Hamaker, M.E.1
Hamelinck, V.C.2
van Munster, B.C.3
-
115
-
-
84864917849
-
Use of geriatric assessment for older adults in the oncology setting: a systematic review
-
Puts MT, Hardt J, Monette J et al. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012; 104: 1134-1164.
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 1134-1164
-
-
Puts, M.T.1
Hardt, J.2
Monette, J.3
-
116
-
-
24044454968
-
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
-
Extermann M, Aapro M, Bernabei R et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55: 241-252.
-
(2005)
Crit Rev Oncol Hematol
, vol.55
, pp. 241-252
-
-
Extermann, M.1
Aapro, M.2
Bernabei, R.3
|